日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The CrescNet Registry Achondroplasia Module: Real-World Demographic Data and Clinical Outcomes in Untreated and Vosoritide-Treated Individuals

CrescNet注册软骨发育不全模块:未经治疗和接受Vosoritide治疗的患者的真实世界人口统计数据和临床结果

Mohnike, Klaus; Beger, Christoph; Gausche, Ruth; Hoyer-Kuhn, Heike; Muschol, Nicole; Palm, Katja; Rohrer, Tilman R; Sredkova, Maria; Streata, Ioana; Wechsung, Katja; Woelfle, Joachim; Zeman, Jiří; Eibenstein, Ursula; Pimenta, Jeanne M; Reichert, Anja; Pfäffle, Roland

Clinical expert opinion on the role of elosulfase alfa in non-ambulatory individuals with Morquio A syndrome

关于elosulfase alfa在患有Morquio A综合征的非行走患者中的作用的临床专家意见

de Souza, Carolina F M; Burton, Barbara K; Campeau, Philippe M; Giugliani, Roberto; Guffon, Nathalie; Lampe, Christina; Muschol, Nicole; Sivri, Serap; Solano, Martha; Stepien, Karolina M

Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease

酶替代疗法和米格司他对于法布里病女性患者疾病进展的影响

Lenders, Malte; Nowak, Albina; Cybulla, Markus; Kaufeld, Jessica; Köhn, Anja Friederike; Muschol, Nicole Maria; Kurschat, Christine; Brand, Eva

Evolution of mobility, pain/discomfort, self-care, and mental health in patients with alpha-mannosidosis: an international caregiver and patient survey

α-甘露糖苷酶缺乏症患者的活动能力、疼痛/不适、自我护理和心理健康状况的变化:一项国际照护者和患者调查

Stepien, Karolina M; Thomas, Sophie; Hennermann, Julia B; Lampe, Christina; Muschol, Nicole M; Ballesta-Martínez, Maria Juliana; Cruz, Jordi; López-Rodríguez, Mónica; Barth, Anneliese; Magner, Martin; Lund, Allan M; Plaiasu, Vasilica; Ballabeni, Andrea; Donà, Francesca; Morgan, Heather M; Guffon, Nathalie

Impact of migalastat on cerebral outcomes in fabry disease - results from the prospective observational FAMOUS trial

米格司他治疗法布里病脑部结局的影响——来自前瞻性观察性FAMOUS试验的结果

Choudhury, Momoko; Lenders, Malte; Laufer, Pauline; Masthoff, Max; Canaan-Kühl, Sima; Kurschat, Christine; Muschol, Nicole; Hennermann, Julia B; Cybulla, Markus; Kaufeld, Jessica; Brand, Eva; Bischof, Antje

Exploring the long-term use of ambroxol in Gaucher disease type 2: insights from two pediatric cases

探讨氨溴索在戈谢病2型中的长期应用:来自两例儿科病例的启示

Aries, Charlotte; Köhn, Anja; Täuber, Karolin; Rudolph, Cornelia; Böttcher, Tobias; Bauer, Peter; Fischer, Steffen; Muschol, Nicole

A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany

德国慢性酸性鞘磷脂酶缺乏症发病率和死亡率的回顾性研究

Mengel, Eugen; Muschol, Nicole; Weinhold, Natalie; Ziagaki, Athanasia; Neugebauer, Julia; Antoni, Benno; Langer, Laura; Gasparic, Maja; Guillonneau, Sophie; Fournier, Marie; Laredo, Fernando; Pulikottil-Jacob, Ruth

Impact of enzyme replacement therapy on clinical manifestations in females with Fabry disease

酶替代疗法对法布里病女性患者临床表现的影响

Lenders, Malte; Nowak, Albina; Cybulla, Markus; Kaufeld, Jessica; Köhn, Anja Friederike; Muschol, Nicole Maria; Kurschat, Christine; Brand, Eva

Long-Term Outcome of Infantile Onset Pompe Disease Patients Treated with Enzyme Replacement Therapy - Data from a German-Austrian Cohort

接受酶替代疗法治疗的婴儿期发病庞贝病患者的长期预后——来自德国-奥地利队列的数据

Pfrimmer, Charlotte; Smitka, Martin; Muschol, Nicole; Husain, Ralf A; Huemer, Martina; Hennermann, Julia B; Schuler, Rahel; Hahn, Andreas

Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease

VEGFα 在 α-GAL-Tg/KO 小鼠主动脉组织中的过度表达作为内皮功能障碍的生物标志物,以及其在法布里病患者血清中的上调

N Lund, H Wieboldt, L Fischer, N Muschol, F Braun, T Huber, D Sorriento, G Iaccarino, K Müllerleile, E Tahir, G Adam, P Kirchhof, L Fabritz, M Patten